SS
KALA icon

Steve Schonfeld’s KALA BIO KALA Stock Holding History

Steve Schonfeld’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16
Closed -$216K – 2310
2021
Q2 		$216K Sell
16
-1
-6% -$15.7K ﹤0.01% 1632
2021
Q1 		$290K Buy
+17
New +$332K ﹤0.01% 1347
2020
Q4 		– Sell
-20
Closed -$368K – 1717
2020
Q3 		$368K Buy
+20
New +$460K 0.01% 1014

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Steve Schonfeld's KALA Position: Q3 2021 in Review

Steve Schonfeld sold out of KALA BIO (KALA) in Q3 2021, closing a stake of 16 shares — an estimated $216K sold.

Steve Schonfeld first reported a position in KALA in Q3 2020 and held it in 3 quarters. The position peaked at $368K in Q3 2020. 99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

  • Steve Schonfeld reported no remaining KALA BIO position as of Q3 2021 after selling out during the quarter.
  • Steve Schonfeld sold 16 KALA BIO shares in Q3 2021, an estimated $216K.
  • Steve Schonfeld first reported a position in KALA BIO in Q3 2020 and held it in 3 quarters.
  • Steve Schonfeld's KALA BIO position peaked at $368K in Q3 2020.
  • 99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.